New Antifungal Drugs, New Approaches and Vaccines

Scynexis (SCYX) Announces Results from Two Completed SCY-078 Phase 2s; Closes $15 Term Loan

14 October 2016

CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility.

10 August 2016

BSG005 for Systemic Fungal Infections

11 August 2016

New applications for known drugs: Human glycogen synthase kinase 3 inhibitors as modulators of Aspergillusfumigatus growth.

30 June 2016

MAT2203: Encochleated Formulation of Amphotericin B

18 July 2016

Matinas BioPharma Announces Presentation of Cryptococcal Meningitis Preclinical Data of MAT2203 at AIDS-Associated Mycosis Meeting 2016

18 July 2016

Matinas BioPharma Receives Issuance of Key U.S. Patent for Novel Lipid-Crystal Nano-Particle Cochleate Formulation Technology

18 July 2016

AR-12 Abstracts Accepted for Podium Presentation and Three Posters at ICAAC/ICC Annual Meeting 2015

15 July 2016

Arno Therapeutics Receives European Orphan Drug Designation for AR-12 to Treat Two Infectious Diseases

15 July 2016

Arno Therapeutics Data Demonstrate AR-12 as Novel Antifungal Drug Against Common Finger and Toenail Fungus, Onychomycosis

15 July 2016